As of June 30, 2018, we had 81 (2017: 75) employees globally:
59% of our employees are based in the United States where the Mesoblast operational activities are concentrated.
Australia is corporate headquarters with 30% of the employees work. This includes the CEO and the majority of the Executive team.
The remaining 11% of employees are located in Singapore (10%) and 1% in Switzerland where research and technology transfer activities are conducted.